Bone Care International to Present at the Roth Capital Partners 17th Annual Growth Stock Conference.MIDDLETON, Wis. -- Bone Care International, Inc. (Nasdaq:BCII) today announced that Paul L. Berns, President and Chief Executive Officer, and Brian J. Hayden, Vice President-Finance and CFO See Chief Financial Officer. , will be presenting at 1:30 pm PST on Tuesday, February 22, 2005, at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, 17th Annual Growth Stock Conference at the St. Regis Monarch Beach Resort in Dana Point, CA. The presentation will be webcast live and available for replay for 90 days. The direct link to the webcast is: http://www.wsw.com/webcast/roth5/bcii/. E[acute accent]Bone Care International (www.bonecare.com) is a specialty pharmaceutical company engaged in the discovery, development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating de·bil·i·tat·ing adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction conditions and life-threatening diseases. Our current commercial and therapeutic focus is in nephrology, utilizing Hectorol(R) (doxercalciferol), our novel vitamin D hormone Vitamin D hormone Vitamin D is a vitamin that also acts as a hormone. Vitamin D hormone acts with parathyroid hormone to regulate calcium levels in the blood and to supply appropriate amounts of calcium to all cells. Mentioned in: Hypercalcemia therapy, to treat secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is and end-stage renal disease End-stage renal disease (ESRD) Total kidney failure; chronic kidney failure is diagnosed as ESRD when kidney function falls to 5-10% of capacity. Mentioned in: Chronic Kidney Failure end-stage renal disease . In addition to chronic kidney disease, the Company is developing vitamin D hormone therapies to treat hyperproliferative disorders such as cancer and psoriasis. E[acute accent]About the Roth Capital Partners 17th Annual Growth Stock E[acute accent]Conference E[acute accent]This conference will feature more than 220 leading growth companies in sectors such as Technology, Healthcare, Financial Services and Consumer Products. A concentrated, two-day program will allow institutional investors to meet the executives from a select group of companies that have been hand picked by the Roth Capital Partners research team. 40% of this year's participating companies are presenting here for the first time. The average market cap of this year's presenters is around $330 million, with the median around $185 million. This closely mirrors the average and median market cap Median market cap The midpoint of market capitalization (market price multiplied by the number of shares outstanding) of the stocks in a portfolio. Half the stocks in the portfolio will have higher market capitalizations; half will have lower. for the proposed Russell Microcap(tm) Index which is expected to be around $277 million and $176 million respectively. E[acute accent]To register for this conference, please contact your Roth sales representative at 800-678-9147. Please note that this conference is by invitation only. E[acute accent]For more information about the conference visit: http://www.rothcp.com/2005%20DP%20Conference%20Web%20Site/ Roth%20DP.html?content=home. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion